Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2024-03-07 00:00:00 ET · period of report 2024-03-07 · accession 0001579587-24-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-07 | 2024-03-07 | ANIP | Marken James G. | SVP OPS, PROD DEV | S - Sale | $66.37 | -24.3K | 124.5K | -16% | -$1.62M | |
| 2024-03-07 | 2024-03-07 | ANIP | Marken James G. | SVP OPS, PROD DEV | F - Tax | $66.71 | -2,034 | 122.5K | -2% | -$135.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-07 | S | D | 24,338 | $66.37 | 124,492 | D | — | — | (F1) The shares were sold in multiple trades at prices ranging from $66.00 to $66.75. The price reported above reflects the weighted average sales price. |
| 2 | Common | Common Stock | 2024-03-07 | F | D | 2,034 | $66.71 | 122,458 | D | — | — |